Drug
Opc 262
Opc 262: highest development phase Phase 3, developed by Kyowa Kirin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPC-262 NCT01046318 | Phase 3 | Type 2 Diabetes |
| OPC-262 NCT01193179 | Phase 3 | Diabetes, Type 2 |
Latest
No recent events.
Follow Opc 262 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.